Jimmy Teng, senior associate at Munich Re Ventures, is one of our top 50 Rising Stars in corporate venturing for 2025.
Jimmy Teng’s interest in healthcare startups began when he worked in his first investment role at Fusion Fund, an early-stage VC company based in Palo Alto. He then joined MIT’s deeptech VC, the E14 Fund, investing in startups and spinouts from students, researchers, and alumni.
Now, he works at Munich Re Ventures, the US-based CVC arm of the German multinational reinsurance company Munich Re, where he continues to invest in healthcare. He is passionate about the sector because he feels it can have a real-world impact.
“In another five years, I will be fulfilled knowing that I’ve spent a decade backing companies and founders who are benefiting patients, doctors, nurses, and making our healthcare system a better place,” he says.
Teng enjoys the versatility. One of his favourite aspects of working at Munich Re Ventures is the freedom he is given to explore topics he finds interesting and to be creative with investment themes. The team is close-knit too: Teng says he knows most of the families of people he works with at the fund, and they often meet in their spare time.
“I will be fulfilled knowing that I’ve spent a decade backing companies and founders who are benefiting patients, doctors, nurses, and making our healthcare system a better place”
While “it’s always fun to meet with brilliant entrepreneurs,” there are a lot of responsibilities to juggle, with board observer roles, managing a team while doing research on a new investment topic and having fires that need to be put out while being available for your portfolio companies. Performing well requires time management and the ability to balance these different parts of the job.
Teng is enthusiastic about the rapid adoption of generative and clinical AI in healthcare, including the potential for fully autonomous medical X-ray in the near future. He is also closely following the rise of GLP-1 drugs and the accompanying challenges for insurance coverage and employers, and sees opportunities for venture-backed startups to enable more providers to transition to value-based care models.
See the full list of Rising Stars 2025 here.
